Skip to main content
SpringerLink
Log in

Gastric Cancer Precursor Lesions and Helicobacter pylori Infection in Patients with Partial Gastrectomy for Peptic Ulcer

  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

The mucosa of the gastric stump is considered at greater risk of dysplastic and neoplastic changes than that of the intact stomach. The combination of enteric reflux and Helicobacter pylori infection may have a synergistic damaging effect on the mucosa of the gastric remnant, both producing and increasing mucosal proliferation. The aim of this study was to assess whether the occurrence of H. pylori infection in the remnant mucosa of partially gastrectomized subjects for peptic ulcer disease is associated with an increase of the mucosal precursor lesions of malignancy. A series of 151 subjects who underwent partial gastrectomy for peptic ulcer disease were submitted to upper digestive endoscopy for long-term surveillance. Biopsy specimens of the gastric stump were tested for the occurrence of H. pylori infection and for the presence of precancerous mucosal lesions. The prevalence of H. pylori colonization in the remnant stomach was less than 30% and similar in subjects with different time intervals between gastrectomy and endoscopy. Age at surgery (χ2: p = 0.03) and H. pylori infection (χ2: p = 0.002) were significantly associated with the grading of mucosal lesions. The prevalence of normal mucosa was 10 times higher in H. pylori-negative patients as in H. pylori-positive ones (22.0% vs. 2.4%), and the prevalence of intestinal metaplasia was four times higher in H. pylori-positive patients than in H. pylori-negative ones (19.6% vs. 4.6%). We concluded that H. pylori infection may play a causal role in the development of gastric lesions in the operated stomach.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ganellin CR, Durant GJ, Emmett JC. Some chemical aspects of histamine H2-receptor antagonists. Fed. Proc. 1976;35:1924–1930

    PubMed  Google Scholar 

  2. Warren JR, Marshall BJ. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983;1:1273–1275

    PubMed  Google Scholar 

  3. Clark CG, Ward MWN, McDonald AM, et al. The incidence of gastric stump cancer. World J. Surg. 1983;7:236–240

    Article  PubMed  Google Scholar 

  4. Caygill CPJ, Hill M, Kirkham JS, et al. Mortality from gastric cancer following gastric surgery for peptic ulcer. Lancet 1986;2:929–931

    Article  PubMed  Google Scholar 

  5. Offerhaus GJA, Tersmette AC, Huibregtse K, et al. Mortality caused by stomach cancer after remote partial gastrectomy for benign condition: 40 years of follow-up of an Amsterdam Cohort of 2633 postgastrectomy patients. Gut 1988;29:1588–1590

    PubMed  Google Scholar 

  6. Northfield TC, Hall CN. Carcinoma of the gastric stump: risks and pathogenesis. Gut 1990;31:1217–1219

    PubMed  Google Scholar 

  7. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process: first American Society award lecture on cancer epidemiology and prevention. Cancer Res. 1992;52:6735–6740

    PubMed  Google Scholar 

  8. Weiman TJ, Max MH, Vogles CR, et al. Diversion of duodenal contents: its effect on the production of experimental gastric cancer. Arch. Surg. 1980;115:959–961

    PubMed  Google Scholar 

  9. Sano C, Kumashiro R, Saito T, et al. Promoting effect of partial gastrectomy on carcinogenesis in the remnant stomach of rats after oral administration of N-methyl-N-nitro-N-nitrosoguanidine. Oncology 1984;41:124–128

    PubMed  Google Scholar 

  10. Forman D, Newell DG, Fullerton F, et al. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. B.M.J. 1991;302:1302–1305

    Google Scholar 

  11. Nomura A, Stemmerman G, Chyou MJ, et al. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N. Engl. J. Med. 1991;325:1132–1136

    PubMed  Google Scholar 

  12. Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N. Engl. J. Med. 1991;325:1127–1131

    PubMed  Google Scholar 

  13. Lauwers GY. Defining the pathologic diagnosis of metaplasia, atrophy, dysplasia and gastric adenocarcinoma. J. Clin. Gastroenterol. 2003;36:537–543

    Article  Google Scholar 

  14. International Agency for Research on Cancer (IARC) Working Group. IARC Monograph on the Evaluation of Carcinogenic Risk to Humans. Vol. 61: Schistosomes, Liver Flukes and Helicobacter pylori. Lyon, IARC, 1994

  15. Offerhaus GJ, Rieu PN, Jansen JB, et al. Prospective comparative study of the influence of postoperative bile reflux on gastric mucosal histology and Campylobacter pylori infection. Gut 1989;30:1552–1557

    PubMed  Google Scholar 

  16. Mathai E, Arora A, Cafferkey M, et al. The effect of bile acids on the growth and adherence of Helicobacter pylori. Aliment. Pharmacol. Ther, 1991;5:653–658

    Google Scholar 

  17. Leivonen M, Nordling S, Haglund C. Does Helicobacter pylori in the gastric stump increase the cancer risk after certain reconstruction types? Anticancer Res. 1997;17:3893–3896

    PubMed  Google Scholar 

  18. Lynch DAF, Mapstone NP, Clarke AMT, et al. Cell proliferation in the gastric corpus in Helicobacter pylori associated gastritis and after gastric resection. Gut 1995;36:351–353

    PubMed  Google Scholar 

  19. Correa P. A human model of gastric carcinogenesis Cancer Res. 1988;48:3554–3560

    PubMed  Google Scholar 

  20. Correa P, Fox J, Fontham E, et al. Helicobacter pylori and gastric carcinoma: serum antibody prevalence in populations with contrasting cancer risks. Cancer 1990;66:2569–2574

    PubMed  Google Scholar 

  21. Forman D, Sitas F, Newel DG, et al. Geographic association of Heli’cobacter pylori antibody prevalence and gastric cancer mortality in rural China. Int. J. Cancer 1990;46:608–611

    PubMed  Google Scholar 

  22. Talley NJ, Zinsmeister AR, Weaver A, et al. Gastric adenocarcinoma and Helicobacter pylori infection. J. Natl. Cancer Inst. 1991;83:1734–1739

    PubMed  Google Scholar 

  23. Graham DY. Helicobacter pylori infection is the primary cause of gastric cancer. J. Gastroenterol. 2000;35(Supp 12):90–97

    PubMed  Google Scholar 

  24. Ritchie WP. Alkaline reflux gastritis: a critical reappraisal. Gut 1984;25:975–987

    PubMed  Google Scholar 

  25. Burden WR, Hodges RP, Hju M. Alkaline reflux gastritis. Surg. Clin. North Am. 1991;71:33–44

    PubMed  Google Scholar 

  26. Kaminishi M, Shimuzu N, Shiomoyama S, et al. Etiology of gastric remnant cancer with special reference to the effects of denervation of the gastric mucosa. Cancer 1995;75(Supp 6):1490–1496

    PubMed  Google Scholar 

  27. Willis B, Lynch DAF, Prescott R, et al. Cell proliferation in the post-surgical stomach, dietary salt, and the effect of Helicobacter pylori eradication. J. Clin. Pathol. 1999;52:665–669

    PubMed  Google Scholar 

  28. Lipkin M. Biomarkers of increased susceptibility to gastrointestinal cancer: new applications to studies of cancer prevention in human subjects. Cancer Res. 1998;48:235–245

    Google Scholar 

  29. Giuliani A, Spada S, Corona M, et al. Cancer precursor lesions in intact stomach Helicobacter pylori gastritis and in resected stomach gastritis. J. Exp. Clin. Cancer Res. 2003;22:371–378

    PubMed  Google Scholar 

  30. Lahner E, Vaira D, Figura N, et al. Role of non-invasive tests (13C-urea breath test and stool antigen test) as additional tools in diagnosis of Helicobacter pylori infection in patients with atrophic body gastritis. Helicobacter 2004;9:436–442

    Article  PubMed  Google Scholar 

  31. Moayyedi P, Dixon MF. Any role left for invasive tests? Histology in clinical practice. Gut 1998;43:S51–S55

    PubMed  Google Scholar 

  32. Lotterer E, Ludtke FE, Tegeler R, et al. The 13C-urea breath test detection of Helicobacter pylori infection in patients with partial gastrectomy. Z. Gastroenterol. 1993;31:115–119

    PubMed  Google Scholar 

  33. Danesh J, Appleby P, Peto R. How often does surgery for peptic ulceration eradicate Helicobacter pylori? Systematic review of 36 studies. B.M.J. 1998;316:746–747

    Google Scholar 

  34. Goodwin CS, Armstrong JA, Marshall BJ. Campylobacter pylori, gastritis and peptic ulceration. J. Clin. Pathol. 1986;39:353–365

    PubMed  Google Scholar 

  35. Tompkins DS, West AP. Campylobacter pylori, acid, and bile. J. Clin. Pathol. 1987;40:1387

    Google Scholar 

  36. Rokkas T, Filipe MI, Sladen GE. Detection of an increased incidence of early gastric cancer in patients with intestinal metaplasia type III who are closely followed up. Gut 1991;32:1110–1113

    PubMed  Google Scholar 

  37. Filipe MI, Munoz N, Matko J, et al. Intestinal metaplasia types and the risk of gastric cancer: a cohort study in Slovenia. Int. J. Cancer 2001;57:324–329

    Google Scholar 

  38. Leung WK, Sung JJY. Review article: intestinal metaplasia and gastric carcinogenesis. Aliment. Pharmacol. Ther. 2002;16:1209–1216

    Article  PubMed  Google Scholar 

  39. El-Ziniaity HM, Ramchatesingh J, Saeed MA, et al. Gastric intestinal metaplasia: subtypes and natural history. J. Clin. Pathol. 2001;54:679–683

    PubMed  Google Scholar 

  40. Safatle-Ribeiro AV, Ribeiro U Jr, Clarke MR, et al. Relationship between persistence of Helicobacter pylori and dysplasia, intestinal metaplasia, atrophy, inflammation, and cell proliferation in partial gastrectomy. Dig. Dis. Sci. 1999;44:243–252

    Article  PubMed  Google Scholar 

  41. Barbosa J, Dinis-Ribeiro M, Guilherme M, et al. Use of Helicobacter pylori-specific antibodies in the evaluation of intestinal metaplasia and gastric dysplasia. Br. J. Biomed. Sci. 2003;60:175–179

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery “P. Valdoni”, University La Sapienza, Rome, Italy

    Andrea Giuliani M.D., Alessandro Caporale M.D., Martino Demoro M.D., Eugenio Benvenuto M.D. & Massimo Scarpini M.D.

  2. Department of Clinics and Applied Medical Therapy, University La Sapienza, Rome, Italy

    Sebastiano Spada M.D.

  3. IV Division of Internal Medicine, Department of Experimental Medicine and Pathology, University La Sapienza, Rome, Italy

    Francesco Angelico M.D.

Authors
  1. Andrea Giuliani M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alessandro Caporale M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Martino Demoro M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Eugenio Benvenuto M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Massimo Scarpini M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Sebastiano Spada M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Francesco Angelico M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Francesco Angelico M.D..

Rights and permissions

Reprints and permissions

About this article

Cite this article

Giuliani, A., Caporale, A., Demoro, M. et al. Gastric Cancer Precursor Lesions and Helicobacter pylori Infection in Patients with Partial Gastrectomy for Peptic Ulcer. World J. Surg. 29, 1127–1130 (2005). https://doi.org/10.1007/s00268-005-7713-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-005-7713-4

Keywords

Search

Navigation